logo

For the Inventor, By the Inventor

Takatsuki, Japan

Masayasu Enomoto

This inventor holds 7 USPTO granted patents. Top assignees: Nippon Shoji Kaisha Ltd., Nippon Shoji Kabushiki Kaisha. Active years: 1986-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masayasu Enomoto. Retrieved from https://idiyas.com/inventor/masayasu-enomoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 1.3

ph-index = 6

Forward Citations = 65(Granted Patents)


Company Filing History:

goldMedal4 out of 10 
 
Nippon Shoji Kaisha Ltd.
 patents
silverMedal3 out of 8 
 
Nippon Shoji Kabushiki Kaisha
 patents

Years Active: 1986-1998

Loading Chart...
7 patents (USPTO):Explore Patents
1. 5851836 - Method for determining fibrinogen and reagent for determination thereof (1998-12-22),
2. 5646007 - Method for determination of antithrombin III activity and reagent kit (1997-07-08),
3. 5508202 - Method of determining blood coagulation factor XIII activity and kit of (1996-04-16),
4. 5221614 - Method and reagent for determining the biological activity of (1993-06-22),
5. 5147803 - Method and composition for stabilizing blood coagulation factors and (1992-09-15),
6. 5093237 - Method and reagent for determining the biological activity of (1992-03-03),
7. 4571383 - Reagent for measuring direct bilirubin by enzymatic method and method (1986-02-18),

Title: Masayasu Enomoto: Innovator in Fibrinogen Determination

Introduction

Masayasu Enomoto is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the determination of fibrinogen and antithrombin III activity. With a total of 7 patents to his name, Enomoto's work has had a considerable impact on clinical practices.

Latest Patents

One of Enomoto's latest patents is a method for determining fibrinogen concentration. This innovative approach involves adding thrombin or a protease inhibitor to an undiluted test sample, converting fibrinogen into fibrin. The determination of coagulation time occurs in a reaction mixture containing a high concentration of salt, allowing for simplified testing without the need to dilute the sample. Another significant patent is the method for determining antithrombin III activity, along with a reagent kit designed for this purpose.

Career Highlights

Throughout his career, Enomoto has worked with prominent companies such as Nippon Shoji Kaisha Ltd. and Nippon Shoji Kabushiki Kaisha. His expertise in medical diagnostics has positioned him as a key figure in the development of innovative testing methods.

Collaborations

Enomoto has collaborated with notable colleagues, including Masahiro Yamaguchi and Masaharu Takayama. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Masayasu Enomoto's contributions to the field of medical diagnostics through his innovative patents have significantly enhanced the accuracy and efficiency of fibrinogen and antithrombin III determination. His work continues to influence clinical practices and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…